OpportunityTitle: DoD Peer Reviewed Alzheimer&apos;s Quality of Life Research Award
Description: The intent of the research funded through the FY14 Quality of Life Research Award (QUAL) is to reduce the burden on caregivers and individuals affected by the common symptoms of both TBI and AD, especially in the military community.Overarching Challenges: This QUAL funding opportunity requires applications to address one or both of the following PRARP Overarching Challenges:Quality of Life: The need for technologies, tests, interventions, epidemiological studies, or devices with the potential to benefit individuals suffering from common symptoms of TBI and AD.Caregiver Burden: The need for technologies, tests, interventions, epidemiological studies, or devices with the potential to reduce caregiver burden for individuals affected by the common symptoms of TBI and AD.Focus Areas: In addition to addressing one or both of the specified Overarching Challenges, applications must also address at least one of the following FY14 PRARP Focus Areas in support of the specified Overarching Challenge(s). An application that proposes research outside of these Focus Areas is acceptable, as long as the applicant provides a strong rationale:Care Interventions and Quality of Life: Research intended to stabilize or improve the quality of life of those affected by the common symptoms of TBI and AD. Examples of research in this focus area include:Cognitive Training InterventionsStudies of Health and WellnessBehavioral InterventionsNeuropsychological InterventionsCaregiver support: Research intended to reduce the burden of care on the caregiver for individuals affected by the common symptoms of TBI and AD.Examples of research in this focus area include:Caregiver TrainingHome Based SupportBehavioral InterventionsRelationship InterventionsWhile the QUAL mechanism can be used to support clinical research, the following is specifically discouraged under the FY14 PRARP:Pharmacologic Interventions: Clinical or Basic research requiring investigational or FDA-approved drugs or medicines.Drug Discovery and Development: Clinical or Basic research directly leading to the development of investigational medicines, drugs or agents.
GrantorContactEmailDescription: CDMRP Help Desk
GrantorContactText: CDMRP Help Desk &lt;br/&gt;Phone: 301-682-5507 &lt;br/&gt; &lt;br/&gt;